贝达药业：目前公司八款上市药品销售推广稳步推进

Group 1 - The core viewpoint of the article highlights that Beida Pharmaceutical (300558) is experiencing steady sales growth for its eight listed drugs and is gradually expanding into overseas markets [1] - The company is concentrating resources on the development of key projects and is increasing its investment in new targets and technologies to expedite the launch of new products [1]